Alterity Therapeutics Ltd

ATHE

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001131343

SEC filings (opens in a new tab)

In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.

Other share classesPRNAF

Q2 2021 vs. Q1 2021

How the institutions holding Alterity Therapeutics Ltd changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of ATHE: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Q2 2021	Change
Holders	12	14	+2
Shares	1.00M	990.4K	−13.9K (−1.4%)
Value	$1.45M	$1.29M	−$160.1K (−11.1%)

New holders (3)

Institutions that held Alterity Therapeutics Ltd at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ATHE in Q2 2021
Institution	Shares	Value	% of portfolio
Millennium Management LLC	36,937	$48.0K	0.00%
HRT Financial LP	27,992	$36.0K	0.00%
FMR LLC	1	$0	0.00%

Sold out (1)

Institutions that held Alterity Therapeutics Ltd at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ATHE in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Virtu Financial LLC	69,905	$101.0K